Tafenoquine following G6PD screening versus primaquine for the treatment of vivax malaria in Brazil: A cost-effectiveness analysis using a transmission model.
David J PriceNarimane NekkabWuelton Marcelo MonteiroDaniel Antunes Maciel VillelaJulie Anne SimpsonMarcus Vinícius Guimarães de LacerdaMichael T WhiteAngela DevinePublished in: PLoS medicine (2024)
In our modelling study that incorporated impact on transmission, tafenoquine prescribed after a semiquantitative G6PD testing was highly likely to be cost-effective in Brazil. These results demonstrate the potential health and economic importance of ensuring safe and effective radical cure.